Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Csizmadia, Ilona"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leon, Gemma, Hernandez Santana, Yasmina E., Irwin, Naoise, Giannoudaki, Eirini, O'Neill, Sadhbh, Csizmadia, Ilona, Gogarty, Martina, Lee, Tae J., Ruane, Darren, Long, Aideen, Fallon, Padraic G., Hussey, Seamus, Walsh, Patrick T.
Publikováno v:
Mucosal Immunology (1933-0219); Mar2022, Vol. 15 Issue 3, p491-503, 13p
Autor:
Mähler, Anja, Balogh, Andras, Csizmadia, Ilona, Klug, Lars, Kleinewietfeld, Markus, Steiniger, Jochen, Šušnjar, Urša, Müller, Dominik N., Boschmann, Michael, Paul, Friedemann
Publikováno v:
Frontiers in Immunology
Background: Physical activity might attenuate inflammation and neurodegeneration in multiple sclerosis (MS). Erythropoietin, which is produced upon exposure to hypoxia, is thought to act as a neuroprotective agent in MS. Therefore, we studied the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::311c63033aafcbd5b3fc5a8febc25b2f
http://edoc.mdc-berlin.de/17928/2/17928suppl.pdf
http://edoc.mdc-berlin.de/17928/2/17928suppl.pdf
Autor:
Leon, Gemma, Hernandez Santana, Yasmina E., Irwin, Naoise, Giannoudaki, Eirini, O'Neill, Sadhbh, Csizmadia, Ilona, Gogarty, Martina, Lee, Tae J., Ruane, Darren, Long, Aideen, Fallon, Padraic G., Hussey, Seamus, Walsh, Patrick T.
Publikováno v:
Mucosal immunology; March 2022, Vol. 15 Issue: 3 p491-503, 13p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mähler, Anja, Balogh, Andras, Csizmadia, Ilona, Klug, Lars, Kleinewietfeld, Markus, Steiniger, Jochen, Šušnjar, Urša, Müller, Dominik N., Boschmann, Michael, Paul, Friedemann
Background: Physical activity might attenuate inflammation and neurodegeneration in multiple sclerosis (MS). Erythropoietin, which is produced upon exposure to hypoxia, is thought to act as a neuroprotective agent in MS. Therefore, we studied the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b77ef803ec083539de272aae66d60d7
Autor:
Mähler A; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Centre for Cardiovascular Research Partner Site Berlin, Berlin, Germany., Balogh A; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Centre for Cardiovascular Research Partner Site Berlin, Berlin, Germany.; Max Delbruck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Csizmadia I; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany., Klug L; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Kleinewietfeld M; VIB Laboratory of Translational Immunomodulation, VIB Center for Inflammation Research Hasselt University, Diepenbeek, Belgium., Steiniger J; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany., Šušnjar U; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; International Centre for Genetic Engineering and Biotechnology, Triste, Italy., Müller DN; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; German Centre for Cardiovascular Research Partner Site Berlin, Berlin, Germany.; Max Delbruck Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Boschmann M; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Paul F; Experimental and Clinical Research Center Cooperation Between Charité Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center and Department of Neurology, Charité Universitätsmedizin Berlin Humboldt Universität Berlin, Berlin, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2018 Nov 29; Vol. 9, pp. 2819. Date of Electronic Publication: 2018 Nov 29 (Print Publication: 2018).